FDA’s new target: JUUL use


The JUUL is an electronic cigarette that has become increasingly popular with high school and college students since its release in 2015. Now, the Federal Drug Administration is putting its foot down when it comes to teenage vaping.

Sheila Kaplan and Jan Hoffman of The New York Times wrote a fantastic piece, titled, “F.D.A. Targets Vaping, Alarmed by Teenage Use,” about the FDA’s actions as well as the possible consequences for JUUL and other electronic cigarette companies.

Hoffman and Kaplan make the FDA’s main concern very clear. They are worried that these companied, specifically JUUL, are advertising and purposely selling their product to teenagers. The concern there is obviously that teenagers who have never smoked before will become addicted to nicotine via using these sleek devices. The FDA referred to this as the modern-day version of the Joe Camel advertisements.

The article also took quotes from the spokeswoman for JUUL. They said that they will work with the FDA and comply with them to keep their products out of the hands of teenagers.

While news reporters did a great job portraying both sides of the argument (pro and anti-government regulation) they failed to do one thing. They did not list statistics for how many adults, over the age of 18, have used devices like these to quit smoking, and how that population will be affected. The talk of regulation has been a concern in the vaping community and it would have added another element to the article to voice the concerns of people who have used JUUL and other companies to quit their cigarette addictions.

This is a big issue and one that is very obvious, especially if you walk around a high school or college campus. This article now has put this issue out in to the open for the general public to discuss and debate.